Select
As the central bridge connecting nutrient sensing and cellular activities, mTORC1 has for years drawn much attention in the cell metabolism field. Its frequent dysregulation in cancer and the diverse therapeutic potential of the mTOR inhibitor rapamycin have further spread its acclaim among cancer biologists, clinicians, and pharmaceutical companies. Although efforts have yielded an in-depth understanding of the molecular components that regulate mTORC1 localization and activity at various steps along the signaling cascade, a key issue that has not been adequately addressed is the amino acid specificity in mTORC1 regulation. Does every flavor of amino acid taste the same to mTORC1? If not, how are they distinguished, and perhaps more importantly, why does it matter?
A recent study from the group of Kun-Liang Guan makes a breakthrough in pursing this line of inquiry (Jewell et al., 2015) . RagA and RagB are well-characterized essential regulators for the lysosomal recruitment and activation of mTORC1. Surprisingly, instead of paralyzing the entire mTORC1 pathway, they find that RagA/B deficiency in mouse fibroblasts selectively impairs the ability of mTORC1 in sensing leucine and arginine, while its sensitivity to glutamine remains intact. Together with an earlier work from Michael Hall and colleagues in yeast (Stracka et al., 2014) , the findings highlight the mechanistic differences in TORC1 activation upon stimulation of different amino acids. Further investigation reveals the presence of an ADP ribosylation factor 1 (Arf1)-dependent, Rag-independent pathway for mTORC1 recruitment to the lysosome, suggesting a context-specific role, rather than universal requirement, of Rag in mTORC1 localization. Although this pathway appears to be dedicated to glutamine-mediated mTORC1 regulation and leads to distinct recruitment kinetics compared to its Rag-dependent counterpart, the relative contribution of these two pathways to mTORC1 activation in normal physiological context remains to be determined. As Jewell et al. (2015) mention in their paper, glutamine addiction is a feature shared by a variety of cancer cells. Therefore, it would be intriguing to explore whether this glutamine-specific sensing mechanism would be particularly important in the cancer setting and to test its potential as a target for anti-cancer therapeutic development.
The work in yeast and mouse fibroblasts reinforces the notion that TORC1 does not see every amino acid in the same way and suggests that the mechanisms behind this may be evolutionary conserved. However, this leaves unresolved the identity of the direct amino acid sensor. Two studies from Giulio Superti-Furga and David Sabatini represent the most recent progress toward this goal (Rebsamen et al., 2015; Wang et al., 2015) . The two groups independently characterize a member of the solute carrier family 38, SLC38A9, as a lysosomal membrane-resident amino acid transporter that is required for mTORC1 activation by certain amino acids. The characterization of the amino acid binding and transportation activity of SLC38A9 is exciting and certainly in line with the putative role of SLC38A9 being an amino acid sensor. However, fully supporting this notion requires direct evidence linking amino acid binding and its impact on signal transduction. Moreover, it appears that SLC38A9 has a rather non-specific substrate profile. It is therefore unclear whether, and if so to what extent, SLC38A9 might be involved in differential mTORC1 regulation by various amino acid inputs. In addition to lysosome membrane-based sensors, the work from Jewell et al. (2015) and others suggests that differential sensing occurs even before mTORC1 recruitment to the lysosome. The molecular basis for this early-stage sensing is yet another open question. Indeed, as much as we have already known about mTORC1 regulators, we are just getting started in appreciating the mechanistic intricacy of the amino-acidsensing component of mTORC1 signaling.
